Arbor Rapha Capital Bioholdings Corp. I (Nasdaq: ARCK) is a blank check company sponsored by Arbor Rapha Capital, a firm with a focus on the healthcare and life sciences sector. The SPAC completed its initial public offering in 2021 and targets acquisition opportunities within the biopharmaceutical and broader life sciences industry. In December 2022, the company filed an 8-K current report with the Securities and Exchange Commission, accession number 0001104659-22-125907, reflecting a corporate development during its search for a business combination target. ARCK represents one of a number of healthcare-focused SPACs that came to market during the 2020–2021 blank check wave. Sign up at SpacDesk for full filing history, deal timelines, and sponsor analytics on ARCK and hundreds of other SPACs.